Endometriosis with infertility: A comprehensive review on the role of immune deregulation and immunomodulation therapy

Kamila Kolanska, A. Mékinian, Jaume Alijotas-Reig, Jaume Alijotas‐Reig, Jonathan Cohen, Cohen J, Meryem Cheloufi, Cheloufi M, M. Cheloufi, Lise Selleret, Selleret L, Emmanuelle d'Argent, Emmanuelle d’Argent, d'Argent E, Gilles Kayem, Kayem G, Valverde EE, Enrique Esteve Valverde, Enrique E Valverde, Fain O, O. Fain, Olivier Fain, Marie Bornes, Bornes M, Emile Darai, Darai E, Émile Daraï, Arsene Mekinian, Mekinian A
American journal of reproductive immunology (New York, N.Y. : 1989) · 2020 · vol. 85(3) , pp. e13384 · doi:10.1111/aji.13384 · PMID:33278837 · W3111223546
review OA: closed CC0 ⤵ 55 in-corpus citations
🔓 Open OA copy Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

Endometriosis-associated infertility involves immune deregulation, evidenced by elevated cytokines and autoantibodies, prompting investigation into immunomodulatory therapies like steroids and TNF-α antagonists.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-07, 2026-07-09 · read from full text ⓘ

I can’t access the paper content you provided, because the text is blocked by an anti-bot (Anubis) page that prevents the actual study/review from loading, so I’m unable to summarize the research methods or findings. If you paste the abstract and/or the relevant sections (e.g., introduction, key findings, and limitations), I can produce a 3–5 sentence corpus-style summary that ends with the required endometriosis/adenomyosis relevance statement. The paper title indicates it is a review focused on endometriosis with infertility, immune deregulation, and immunomodulation therapy. This paper is centrally about endometriosis — specifically endometriosis with infertility and the role of immune deregulation and immunomodulation therapy.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

BACKGROUND: Endometriosis is a multifactorial pathology dependent on intrinsic and extrinsic factors, but the immune deregulation seems to play a pivotal role. In endometriosis-associated infertility, this could raise the benefit of immunomodulatory strategies to improve the results of ART. In this review, we will describe (1) sera and peritoneal fluid cytokines and immune markers; (2) autoantibodies; and (3) immunomodulatory treatments in endometriosis with infertility. METHODS: The literature research was conducted in MEDLINE, Embase, and Cochrane Library with the following keywords: "endometriosis", "unexplained miscarriage", "implantation failure", "recurrent implantation failure » and « IVF-ICSI », « biomarkers of autoimmunity", "TNF-α", "TNF-α antagonists", "infliximab", "adalimumab", "etanercept", "immunomodulatory treatment", "steroids", "intralipids", "intravenous immunoglobulins", "G-CSF", "pentoxyfylline". RESULTS: Several studies analyzed the levels of pro-inflammatory cytokines in sera and peritoneal fluid of endometriosis-associated infertility, in particular TNF-α. Various autoantibodies have been found in peritoneal fluid and sera of infertile endometriosis women even in the absence of clinically defined autoimmune disease, as antinuclear, anti-SSA, and antiphospholipid autoantibodies. In few uncontrolled studies, steroids and TNF-α antagonists could increase the pregnancy rates in endometriosis-associated infertility, but well-designed trials are lacking. CONCLUSION: Endometriosis is characterized by increased levels of cytokines and autoantibodies. This suggests the role of inflammation and immune cell deregulation in infertility associated with endometriosis. The strategies of immunomodulation to regulate these immune deregulations are poorly studied, and well-designed studies are necessary.
Full text 1,068 characters · extracted from oa-html · click to expand
Making sure you're not a bot! Loading... You are seeing this because the administrator of this website has set up Anubis to protect the server against the scourge of AI companies aggressively scraping websites. This can and does cause downtime for the websites, which makes their resources inaccessible for everyone. Anubis is a compromise. Anubis uses a Proof-of-Work scheme in the vein of Hashcash, a proposed proof-of-work scheme for reducing email spam. The idea is that at individual scales the additional load is ignorable, but at mass scraper levels it adds up and makes scraping much more expensive. Ultimately, this is a placeholder solution so that more time can be spent on fingerprinting and identifying headless browsers (EG: via how they do font rendering) so that the challenge proof of work page doesn't need to be presented to users that are much more likely to be legitimate. Please note that Anubis requires the use of modern JavaScript features that plugins like JShelter will disable. Please disable JShelter or other such plugins for this domain.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

MeSH descriptors

Endometriosis Immunotherapy Infertility, Female Pregnancy Autoantibodies Autoantibodies Biomarkers Biomarkers Cytokines Cytokines Endometriosis Female Humans Immunity Immunomodulation Immunotherapy Infertility, Female Pregnancy

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (87)

Cited by (50)

Source provenance

europepmc
last seen: 2026-08-13T06:15:24.848197+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:21:30.380497+00:00
License: CC0 · commercial use OK